公司2019年年度权益分派方案为:以公司现有总股本 428126983 股为基数,向全体股东每10股派6.000000元人民币现金(含税;扣税后,A股QFII、RQFII以及持有首发前限售股的个人和证券投资基金每10股派5.400000元;A股持有首发后限售股、股权激励限售股及无限售流通股的个人股息红利税实行差别化税率征收,先按每10股派6.000000元;权益登记日后根据投资者减持股票情况,再按实际持股期限补缴税款【注】;A股持有首发后限售股、股权激励限售股及无限售流通股的证券投资基金所涉红利税,对香港投资者持有基金份额部分按10%征收,对内地投资者持有基金份额部分实行差别化税率征收;B股非居民企业、持有首发前限售股的个人扣税后每10股派现金 5.400000 元,持有无限售流通股的境内个人股东的股息红利税实行差别化税率征收,先按每10股派6.000000元,权益登记日后根据投资者减持股票情况,再按实际持股期限补缴税款)。
国药一致:2019年度利润分配实施公告
Sinopharm: 2019 Profit Distribution Implementation Notice
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.